CTOs on the Move

Summa Health

www.summahealth.org

 
Summa Health is one of the largest integrated delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa also is a founding partner of the BioInnovation Institute in Akron. For more information, visit www.summahealth.org. Summa Health is an Affirmative Action employer that promotes Equal Employment Opportunity and Diversity for all individuals. Women, veterans, members of minority groups, and individuals with disabilities are encouraged to apply.
  • Number of Employees: >100K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Swathi West
 Chief Information Security Officer (CISO) Profile
Justin Catlett
 Vice President, Chief Medical Information Officer Profile

Jobs

Chief Information Security Officer

Summa Health Akron, OH
Details here:
https://summaprod2-lm01.cloud.infor.com:1444/lmghr/CandidateSelfService/controller.servlet?dataarea=lmghr&context.session.key.HROrganization=1000&context.session.key.JobBoard=EXTERNAL&JobPost=1&JobReq=58367

Similar Companies

Cingulate Therapeutics

Cingulate Therapeutics, LLC (CTx) is a privately held biopharmaceutical company focused on the development of new products for the treatment of central nervous system and neurobiological disorders.

Cortex Pharmaceuticals

Cortex Pharmaceuticals is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pedinol Pharmacal

Pedinol Pharmacal is a Farmingdale, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phathom Pharmaceuticals

Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.

Vinta Bio

VintaBio is a life sciences company that specializes in customized process development, GMP manufacturing, and quality control services for cell and gene therapies.